Dr. Philip L. Hooper is on the clinical faculty at the University of Colorado Denver—Division of Endocrinology. His career includes both research and clinical practice. The past decade, he has focused on the pathogenesis of the metabolic syndrome, type 1 diabetes, and type 2 diabetes mellitus. As a section editor for the journal, “Cell Stress and Chaperones”, he translates the field of basic research on cell biology of the stress response to its clinical implications—leading to novel therapies for difficult to treat diseases.

His past education includes: Grinnell College for undergraduate education, University of Tennessee for medical school, Gundersen Clinic La Crosse Wisconsin for internal medicine residency, University of New Mexico for endocrinology fellowship.

After twenty years of clinical endocrinology and caring for over 5,000 patients with type 2 diabetes, Dr. Hooper come to the conclusion that “exercise was the best therapy for this indolent progressive disease improving all of the major features of the disease like hyperglycemia, dyslipidemia, obesity, hypertension, and that I needed to redirect my career to understand the pathogenesis of type 2 diabetes for standard pharmacologic therapies were inadequate.”